These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 5067044)
1. [L-dopa induced psychosis-dyskinesia complex]. Ikeda H; Baba O; Ishino H No To Shinkei; 1972 Mar; 14(3):275-80. PubMed ID: 5067044 [No Abstract] [Full Text] [Related]
2. Levodopa and amantadine in the treatment of Parkinsonism. Critchley E Practitioner; 1972 Apr; 208(246):499-504. PubMed ID: 5031037 [No Abstract] [Full Text] [Related]
3. Start hesitation--a side effect of long-term levodopa therapy. Ambani LM; Van Woert MH N Engl J Med; 1973 May; 288(21):1113-5. PubMed ID: 4697941 [No Abstract] [Full Text] [Related]
4. [Psychiatric complications of L-Dopa treatment of parkinsonism]. Refsum H Tidsskr Nor Laegeforen; 1973 Apr; 93(10):680-5. PubMed ID: 4755082 [No Abstract] [Full Text] [Related]
5. Psychosis and other psychiatric manifestations of levodopa therapy. Celesia GG; Barr AN Arch Neurol; 1970 Sep; 23(3):193-200. PubMed ID: 5456717 [No Abstract] [Full Text] [Related]
6. [Abnormal movements induced by L-Dopa and dopamine metabolism disorders]. Lhermitte F; Rosa A; Comoy E; Bohuon C Rev Neurol (Paris); 1973 Dec; 129(6):313-24. PubMed ID: 4794176 [No Abstract] [Full Text] [Related]
7. [Problems and therapy of L-DOPA-induced dyskinesias]. Völler GW; Deze J; Gundlach U; Muschard F Nervenarzt; 1972 Nov; 43(11):584-6. PubMed ID: 4564994 [No Abstract] [Full Text] [Related]
8. L-dopa induced dyskinesias in 152 patients with Parkinson's disease. Mones RJ; Elizan TS; Siegel G Trans Am Neurol Assoc; 1970; 95():286-7. PubMed ID: 5514393 [No Abstract] [Full Text] [Related]
9. L-dopa in the treatment of parkinsonism. Haleem MA Gerontol Clin (Basel); 1972; 14(4):242-8. PubMed ID: 4634915 [No Abstract] [Full Text] [Related]
10. Long-term effects of levodopa in the severely disabled patient. Sacks OW; Messeloff CR; Schwartz WF JAMA; 1970 Sep; 213(13):2270. PubMed ID: 5468938 [No Abstract] [Full Text] [Related]
11. Modification of Parkinsonism--chronic treatment with L-dopa. Cotzias GC; Papavasiliou PS; Gellene R N Engl J Med; 1969 Feb; 280(7):337-45. PubMed ID: 4178641 [No Abstract] [Full Text] [Related]
12. Side effects of L-dopa treatment. Greenburg J Pa Med; 1971 Apr; 74(4):55-6. PubMed ID: 5147645 [No Abstract] [Full Text] [Related]
13. An analysis of L-dopa-induced dyskinesias in 152 cases of Parkinson's disease. Mones RJ; Elizan TS; Siegel GJ Neurology; 1970 Apr; 20(4):405-6. PubMed ID: 5535050 [No Abstract] [Full Text] [Related]
14. Failures of L-dopa. Paulson GW Ohio State Med J; 1973 Dec; 69(12):896-8. PubMed ID: 4769406 [No Abstract] [Full Text] [Related]
15. Drug-induced dyskinesia--an electrophysiological analysis of dyskinesia induced by L-DOPA and anticholinergic drugs. Mano T Nagoya J Med Sci; 1973 Nov; 36(1):29-48. PubMed ID: 4780532 [No Abstract] [Full Text] [Related]
16. [Results of treatment of Parkinsonism with L-dopa]. De Divitiis E; D'Andrea F; Signorelli CD Sist Nerv; 1970; 22(2):99-108. PubMed ID: 5504563 [No Abstract] [Full Text] [Related]